The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Final analysis results from TITAN: A phase III study of apalutamide (APA) versus placebo (PBO) in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) receiving androgen deprivation therapy (ADT).
 
Kim N. Chi
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Janssen; Merck; Roche
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Constellation Pharmaceuticals; Daiichi Sankyo; ESSA; Janssen; Merck; POINT Biopharma; Roche; Sanofi
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); ESSA (Inst); Janssen (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst)
 
Simon Chowdhury
Honoraria - Clovis Oncology; Novartis
Consulting or Advisory Role - Astellas Pharma; Bayer; BeiGene; Clovis Oncology; Janssen-Cilag; Novartis; Pfizer
Speakers' Bureau - Janssen-Cilag; Pfizer
Research Funding - Sanofi/Aventis (Inst)
 
Anders Bjartell
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen-Cilag
Speakers' Bureau - Astellas Pharma; Bayer; Ferring; Janssen-Cilag
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Ferring (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Ferring; Janssen-Cilag
 
Byung Ha Chung
Honoraria - Amgen; Astellas Pharma; Handok; Ipsen; Janssen; JW Pharmaceutical; Takeda
Research Funding - AstraZeneca; Bayer; Janssen; Myovant Sciences; Pfizer; Roche
 
Andrea Juliana Pereira de Santana Gomes
No Relationships to Disclose
 
Robert Given
Speakers' Bureau - Bayer; Janssen
 
Álvaro Juárez Soto
Honoraria - Janssen
Consulting or Advisory Role - Janssen
Speakers' Bureau - Janssen
Research Funding - Janssen
(OPTIONAL) Uncompensated Relationships - Janssen
 
Axel Stuart Merseburger
Honoraria - Astellas Pharma; Bristol-Myers Squibb; Eisai; Ipsen; Janssen-Cilag; Novartis; Pfizer; Roche; Takeda
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Clovis Oncology; Ipsen; Janssen-Cilag; MSD Oncology
Speakers' Bureau - Ipsen
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Janssen-Cilag (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Ipsen; Janssen-Cilag
 
Mustafa Ozguroglu
Honoraria - Astellas Pharma; Janssen Oncology (Inst); Novartis
Consulting or Advisory Role - AstraZeneca; MSD Oncology
Speakers' Bureau - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca
 
Hirotsugu Uemura
Speakers' Bureau - Bayer; Janssen; MSD; Novartis; Ono Pharmaceutical; Pfizer
Research Funding - Astellas Pharma; AstraZeneca; Janssen; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda
 
Dingwei Ye
No Relationships to Disclose
 
Spyros Triantos
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Suneel Mundle
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Sharon Anne McCarthy
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Julie S. Larsen
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Weili Sun
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Katherine Bevans
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Ke Zhang
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Nibedita Bandyopadhyay
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Neeraj Agarwal
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Exelixis; Foundation Medicine; Foundation One Inc; Janssen Oncology; Lilly; Lilly; Lilly; Medivation/Astellas; Merck; Nektar; Novartis; Pfizer; Pfizer; Pharmacyclics; Seattle Genetics
Research Funding - Active Biotech (Inst); Amgen (Inst); AstraZeneca (Inst); Bavarian Nordic (Inst); Bayer (Inst); BN ImmunoTherapeutics (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Celldex (Inst); Eisai (Inst); Exelixis (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Immunomedics (Inst); Janssen (Inst); Merck (Inst); Newlink Genetics (Inst); Novartis (Inst); Pfizer (Inst); Prometheus (Inst); Rexahn Pharmaceuticals (Inst); Sanofi (Inst); Takeda (Inst); TRACON Pharma (Inst)